Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668588 | 0.88 | — | — | |
| SCHEMBL2608502 | 0.83 | LMNA (0.34) | PSMB8MGLLPSMB5 | |
| SCHEMBL2618714 | 0.82 | MGLL (0.34) | PSMB8MGLLPSMB5ALOX12ADORA3 | |
| SCHEMBL43576 | 0.82 | PSMB8 (0.35) | PSMB8MGLLPSMB5ALOX12ADORA3 | |
| SCHEMBL1603240 | 0.80 | KMT2A (0.33) | PSMB8MGLLPSMB5ALOX12 | |
| SCHEMBL3805679 | 0.80 | MGLL (0.33) | PSMB8MGLLPSMB5ALOX12ADORA3 | |
| SCHEMBL31522720 | 0.80 | PSMB8 (0.34) | PSMB8MGLLPSMB5ALOX12ADORA3 | |
| SCHEMBL14706629 | 0.80 | PSMB8 (0.31) | PSMB8PSMB5 | |
| SCHEMBL21342214 | 0.80 | MGLL (0.31) | MGLL | |
| SCHEMBL1140516 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3784 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4749282-A2 | HOMOGENOUS IMMUNOASSAY WITH COMPENSATION FOR BACKGROUND SIGNAL | IDEXX Laboratories, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-115581847-B | Photodynamic balloon catheter system | 杭州矩正医疗科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4713024-A1 | CONJUGATE AND THE PREPARATION THEREOF | Nanjing University (CN) | 2026-03-25 | — | — | EP | claimed |
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 2026-02-12 | — | — | US | claimed |
| US-20260035410-A1 | THERAPEUTIC PEPTIDES AND METHODS OF PEPTIDE DESIGN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2026-02-05 | — | — | US | claimed |
| US-12516150-B2 | Organic solvent-soluble copolymer polyester, composition for forming ultrafiltration membrane comprising same, and high water permeability reverse osmosis membrane prepared therefrom | TORAY ADVANCED MATERIALS KOREA INC. (KR) | 2026-01-06 | — | — | US | claimed |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| US-12428477-B2 | Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same | ANGIEX, INC. (US) | 2025-09-30 | — | — | US | claimed |
| US-20250195679-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | SHANGHAI HUAOTA BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-06-19 | — | — | US | claimed |
| EP-4494658-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | Shanghai Huaota Biopharmaceutical Co., Ltd. (CN) | 2025-01-22 | — | — | EP | claimed |
| WO-2007083984-A1 | CONJUGATE COMPRISING PHARMACEUTICAL ACTIVE COMPOUND COVALENTLY BOUND TO MUCOADHESIVE POLYMER AND TRANSMUCOSAL DELIVERY METHOD OF PHARMACEUTICAL ACTIVE COMPOUND USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2007-07-26 | — | — | WO | claimed |
| EP-1689846-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | Immunogen, Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| US-20050169933-A1 | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates | IMMUNOGEN, INC. | 2005-08-04 | — | — | US | claimed |
| WO-2005037992-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN, INC. (US) | 2005-04-28 | — | — | WO | claimed |
| EP-0977588-B1 | COUPLING OF UNMODIFIED PROTEINS TO HALOACYL OR DIHALOACYL DERIVATIZED POLYSACCHARIDES FOR THE PREPARATION OF PROTEIN-POLYSACCHARIDE VACCINES | JACKSON H M FOUND MILITARY MED (US) | 2004-10-06 | — | — | EP | claimed |
| US-6613894-B1 | Bonding the nucleoside to a solid support, deprotecting using an acid, reacting with a nucleoside phosphoramidite; oxidizing and coupling a biomolecule to the product | NANOGEN RECOGNOMICS GMBH (DE) | 2003-09-02 | — | — | US | claimed |
| US-6160128-A | Tritioacetylating reagents and processes for preparation thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-12-12 | — | — | US | claimed |
| US-6087328-A | FUNCTIONALIZING A POLYSACCHARIDE WITH ONE OR MORE PENDANT HALOACYL GROUPS, THEN THE FUNCTIONALIZED GROUP IS REACTED WITH PROTEIN OR PEPTIDE TO FORM A COVALENTLY LINKED CONJUGATE, USEFUL AS A VACCINE AGAINST BACTERIA, FUNGI OR VIRUSES | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) | 2000-07-11 | — | — | US | claimed |
| EP-0977588-A2 | COUPLING OF UNMODIFIED PROTEINS TO HALOACYL OR DIHALOACYL DERIVATIZED POLYSACCHARIDES FOR THE PREPARATION OF PROTEIN-POLYSACCHARIDE VACCINES | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998047530-A2 | COUPLING OF UNMODIFIED PROTEINS TO HALOACYL OR DIHALOACYL DERIVATIZED POLYSACCHARIDES FOR THE PREPARATION OF PROTEIN-POLYSACCHARIDE VACCINES | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) | 1998-10-29 | — | — | WO | claimed |